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(parietal). Further investigation of hippocampal electrophysiology 
conducted in slice preparations indicated a modest reduction in efficacy 
of synaptic transmission in the absence of altered synaptic plasticity.  
Together, our data demonstrate that the transgenic PLB2Tau mouse model 
presents with striking behavioural and physiological face validity 
relevant for FTD, driven by the low level expression of mutant FTD hTau.  
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Abstract 
Models of Tau pathology related to frontotemporal dementia (FTD) are essential to 
determine underlying neurodegenerative pathologies and resulting Tauopathy relevant 
behavioural changes. However, existing models are often limited in their translational 
value due to Tau overexpression, and the frequent occurrence of motor deficits which 
prevent comprehensive behavioural assessments. In order to address these limitations, a 
forebrain-specific (CaMKIIα promoter), human mutated Tau (hTauP301L+R406W) knock-in 
mouse was generated out of the previously characterised PLB1Triple mouse, and named 
PLB2Tau. After confirmation of an additional hTau species (~60 kDa) in forebrain samples, 
we identified age-dependent progressive Tau phosphorylation which was coincided with 
the emergence of FTD relevant behavioural traits. In line with the non-cognitive 
symptomatology of FTD, PLB2Tau mice demonstrated early emerging (~ 6 months) 
phenotypes of heightened anxiety in the elevated plus maze, depressive/apathetic 
behaviour in a sucrose preference test and generally reduced exploratory activity in the 
absence of motor impairments. Investigations of cognitive performance indicated 
prominent dysfunctions in semantic memory, as assessed by social transmission of food 
preference, and in behavioural flexibility during spatial reversal learning in a homecage 
corner-learning task.  Spatial learning was only mildly affected and task-specific, with 
impairments at 12-month of age in the corner learning but not in the water maze task. 
Electroencephalographic (EEG) investigations indicated a vigilance-stage specific loss of 
alpha power during wakefulness at both parietal and prefrontal recording sites, and site-
specific EEG changes during non-rapid eye movement sleep (prefrontal) and rapid eye 
movement sleep (parietal). Further investigation of hippocampal electrophysiology 
conducted in slice preparations indicated a modest reduction in efficacy of synaptic 
transmission in the absence of altered synaptic plasticity.  
Together, our data demonstrate that the transgenic PLB2Tau mouse model presents with a 
striking behavioural and physiological face validity relevant for FTD, driven by the low level 
expression of mutant FTD hTau.  
 
Keywords: Frontotemporal Dementia, Tauopathies, Tau, phosphorylation, Cognition, 
Apathy, Anhedonia, Semantic memory, Spatial memory, EEG.  
Highlights [3-5 bullet points] 
 PLB2Tau mice express mutant human Tau without gross overexpression. 
 Age-dependent Tau phosphorylation coincides with onset of behavioural deficits. 
 Behavioural and emotional abnormalities are prominent, early occurring phenotypes. 
 Robust semantic-like but subtle spatial memory impairments are evident. 
 Reduced stage- and region-specific EEG changes and mild changes in hippocampal 
synaptic transmission were identified. 
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Introduction 
The excessive phosphorylation and reduced microtubule (MT) association of the Tau 
protein leads to the formation of insoluble inclusions that are prominent cellular 
pathologies in many types of fronto-temporal dementia (FTD) (Goedert et al., 1988; 
Crowther, 1991). Tau gene mutations underlie ~5% of familial FTD cases with as many as 
40% of all tauopathies,  both sporadic and familial, presenting with Tau positive fronto-
temporal lobar degeneration (see Neumann et al., 2009; Goedert et al., 2012 for reviews). 
Functionally, the majority of exonic FTD Tau variants leads to the promotion of 
phosphorylation, decreased phosphatase association, diminished MT binding and an 
increased propensity for protein self-aggregation (Goedert and Spillantini, 2000). 
Despite a degree of shared common pathology between FTD tauopathies and Alzheimer’s 
disease (AD), both dementias differ significantly in terms of early symptomatic 
presentation due to the divergent anatomical loci of neurodegeneration (Rabinovici et al., 
2007). FTD can be broadly subdivided into behavioural variant FTD (bvFTD), associated 
with degeneration of the prefrontal cortex, and semantic variant FTD (svFTD), in which 
temporal lobe degeneration is primary (Ghosh and Lipp 2013). Although executive 
dysfunction is common in both, svFTD is associated with varying language-based deficits, 
whilst bvFTD manifests with altered emotionality, apathy, disinhibition and social 
withdrawal (see Mendez et al., 2008 for review). Early in FTD, memory and visuospatial 
abilities are relatively preserved (Hutchinson and Mathias, 2007). In contrast, AD emerges 
with pronounced deficits in memory and spatial abilities associated with degeneration of 
hippocampal areas and temporoparietal cortices (Rabinovici et al 2007); disruptions in 
executive function, language and mood are evident only following the spread of pathology. 
Though the symptomology of these dementias may converge as these diseases progress, it 
is clear that initial presentations and underlying pathological events are distinct.  
Numerous human Tau (hTau) mouse models have been generated, exploiting the 
multitude of identified FTD Tau variants. These express hTau either alone (summarised in 
Table 1) or in combination with the AD relevant mutated genes, i.e. the human amyloid 
precursor protein (hAPP) and/or the Presenilin 1 (PS1) gene (Lewis et al., 2001; Oddo et al., 
2003; Platt et al., 2011).  The characterisation of early FTD transgenic lines was hindered by 
brainstem and spinal cord pathology and thus progressive motor deficits (see Lewis et al., 
2000 and Allen et al., 2002 for example), but more recently region-specific promoters have 
somewhat overcome this limitation (Tatebayashi et al., 2002; Platt et al., 2011) allowing a 
more in-depth assessment of behaviour and cognition. It should be noted however that 
cortical-spinal neuronal loss and delayed motor impairments occurred in the Tg4510 model 
despite the use of the CaMKII forebrain specific promoter (Ramsden et al., 2005). Given 
the selection of transgene promoters, Tau isoforms and FTD variants, current models yield 
highly heterogeneous phenotypes (see Table 1).  
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As a consequence of the proportionally higher prevalence of AD, mouse lines have been 
preferentially designed for robust hippocampal transgene expression and often report 
deficits within hippocampus-dependent learning. Only few models have been thoroughly 
investigated for non-cognitive aspects such as altered emotionality and disinhibition, more 
akin to the early symptomatic presentation reported in human FTD cases (Takeuchi et al. 
2011; Van der Jeugd 2013).  
Interestingly, several models with  relatively low transgene expression (0.1-2 fold increase), 
such as a V337M model (Tamemura et al., 2001) as well as our recently published line 66 
(L66) mouse model (Melis et al., 2015) are without deficits in spatial learning despite 
evident tau pathology. The preservation of basic hippocampal function was also recently 
observed in a non-transgenic rat model of FTD, where the intra-hippocampal delivery of 
recombinant hTau induced cognitive impairments related to cognitive flexibility rather 
than spatial memory (Koss et al., 2015). In contrast, the selective expression of mutant 
hTau within the entorhinal cortex (de Calignon et al., 2012) or the expression of paired 
helical filament derived Tau truncation products (Hrnkova et al., 2007; Line 1 in Melis et al., 
2015) appears to preferentially engage AD relevant pathological mechanisms, 
recapitulating Braak stage progression of tau pathology and selectively affecting spatial 
(hippocampal) aspects over those underlying emotional processing and motor function.  
Thus, dependent on variables such as the tau species and level of expression, differential 
pathological processes and regional effects may occur which align phenotypes with the 
symptomology of AD vs. FTD.  
Determining the underlying variables instrumental to such diversity in existing tau models 
has somewhat been hindered. Critical drawbacks relate to pronuclear transgene 
technologies, which results in the integration of multiple gene copies at random sites 
within the genome; this can lead to transgenic mutagenesis and endogenous gene 
silencing. The gross overexpression of transgenes further complicates the inference of 
pathophysiological mechanisms (Gama Sosa et al., 2010): Tau overexpression ranged 
between 1-13 fold over endogenous levels, which is problematic given that the expression 
of wild-type hTau also induced clear histological and behavioural pathology (Spittaels et al., 
1999, Polydoro et al., 2009), as pathogenic mechanisms engaged by mutated vs. non-
mutated hTau variants are likely distinct (Furukawa et al., 2003, Khandelwal et al., 2012). 
However, initial attempts to generate a knock-in FTD mouse model failed to generate overt 
Tau phospho-pathology and the associated behavioural deficits even up to 32 months of 
age (Gilley et al., 2012). The absence of pathology may potentially be a consequence of the 
insertion of a mutant analogue (P290L rather than P301L) into the murine Tau gene. 
Beyond these concerns, cross-model comparison is further complicated by variable 
background strains, which influence phenotypes of emotionality (Podhorna and Brown, 
2002; Salomons et al., 2012) cognition (Brooks et al., 2005), and potentially key features 
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such as phosphorylation, inflammation and neurodegeneration (Stozicka et al., 2010; 
Bailey et al., 2014).  
Here, we characterise the PLB2Tau knock-in mouse, which expresses a single copy of FTD 
hTau (2N4R TauP301L + R406W) alongside endogenous murine Tau. The phenotypic 
characterisation comprised not only Tau pathology and assessment of learning and 
memory performance, but also non-cognitive behaviours such as anxiety, hedonia, motor 
activity and exploration alongside vigilance staging and electrophysiological 
measurements.  
 
Methods 
Animals 
Mice were housed and tested in accordance with UK Home Office regulations. All 
experimental procedures were subject to the University of Aberdeen’s Ethics Board and 
conducted in accordance with the European Directive on the Protection of Animals used 
for Scientific Purposes (2010/63/EU) and the Animal (Scientific Procedures) Act 1986. Mice 
were bred at a commercial vendor (Harlan, UK) and delivered to the local facility 2-3 weeks 
prior to testing. All mice were housed in a climate -maintained (temperature 23±2oC and 
relative humidity 40-60%) holding room under a 12 hour light/dark cycle (lights on 7 am; 
lights off 7 pm), with food and water provided ad libitum. 
PLB2Tau mice were generated by crossing of the previously described heterozygous 
PLB1Double female mice (Platt et al., 2011; Calamai et al., 2013) with heterozygous Cre-
recombinase expressing male mice. PLB1Double mice (C57BL6/J background strain) 
expressed a single human APP-Tau (hAPP770Lon(V717I) +Swe (KM670/671NL) / 2N4R hTauP301L+ R406W) 
gene construct regulated by the murine Ca2+/Calmodulin-dependent Kinase IIα (CaMKIIα) 
promoter inserted via targeted knock-in into the HPRT genomic locus (Fig. 1A). hAPP and 
hTau transgenes within the construct were flanked by LoxP and FRT recognition sites, 
respectively. Accordingly, the progeny from the breeding of PLB1Double X Cre-recombinase 
mice were either wild-type, PLB1Double mice expressing the full APP-Tau gene construct or 
expressed only the Tau gene (Fig 1.B), referred to throughout the manuscript as PLB2Tau 
mice. Wild-type (PLBWT) mice were derived from a parallel PLBWT line (as described in Platt 
et al., 2011). 
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Validation of APP Gene Excision and Routine Genotyping of Transgenic Mice  
Genomic DNA isolated from ear biopsies were screened for transgene expression by means 
of PCR amplification with a modified HPRT primer set (Forward: 5’-
CACTAGCCGTTACCATAGCAACTGC-3’and Reverse: 5’-GCAGTAGCCTCATCATCACTAGATGG-
3’). Determination of successful hAPP excision and thus identification of PLB2Tau mice was 
achieved by size comparison of the PCR amplification product, i.e. PLB1Double mice 
produced a product of ~ 5.6 Kb, whereas PLB2Tau mice expressing only hTau produced a 
product of 2.6 Kb (Fig 1.B).   
hTau regional gene expression 
PLB2Tau transgene expression was confirmed by quantitative PCR (Platt et al., 2011). In 
brief, forebrain and cerebellum samples from 12-month old PLBWT and PLB2Tau mice (n=5 
for both) were treated as per manufactures guideline using the RNeasy lipid tissue mini kit 
(Qiagen). RNA samples were controlled for integrity (Agilent 2100 bioanalyzer, Cheshire, 
UK, RIN-score>7) before cDNA was synthesised with the Transcriptor High Fidelity reverse 
transcriptase kit (Roche, Burgess Hill, UK). The cDNA (100 ng) was run in triplicate with 3.2 
µM hTau transgene specific (Forward: 5’-CACGGACGCTGGCCTGAAAG-3’, Reverse: 5’-
CTGTGGTTCCTTCTGGGATC-3’) and GAPDH housekeeping gene specific (Forward: 5’-
ACTTTGTCAAGCTCATTTCC-3’, Reverse: 5’-TGCAGCGAACTTTATTGATC-3’) primers using a 
BioRad miniOpticon real-Time PCR detection system with iQ SYBR green supermix (Biorad 
Hemel Hempstead, UK). Data analysis was performed using the Opticon monitor TM 
software (Biorad); gene expression values were quantified relative to endogenous GAPDH 
housekeeping gene values. Due to the low transgene expression (cf. GAPDH), normalised 
values were multiplied by a factor of 104, to allow for graphic representation. Regional 
brain expression was assessed by two-tailed Student’s t-test comparison. 
Tau protein expression and phosphorylation 
Mice were sacrificed by cervical neck dislocation, brains snap frozen in liquid nitrogen and 
stored at -80 OC. For soluble protein quantification, hemi-forebrain samples (For hTau 
expression n=6 for 6m PLBWT and PLB2Tau mice and n= 5 for 12m PLBWT and PLB2Tau mice; 
for total Tau and phospho-Tau PHF-1 and CP-13, n=14, 12, 12 and 16 for 6-month old 
PLBWT, PLB2Tau, 12-month old PLBWT and PLB2Tau mice) were homogenised in ~1:10 (W/V)  
Igepal lysis buffer (in mM: 20 HEPES, 150 NaCl, 0.1 EDTA, 1% Igepal: pH=7.6), containing 
complete protease inhibitors (Roche) and PhosStop tablets (Roche), then spun at 4OC for 
20 mins at 12000 revolutions per minute (rpm) and the supernatant separated from pellet. 
The resulting supernatant was additionally heated at 90 OC for 10 mins, spun (10 mins, 
14000 rpm at 4 oC) and the Tau-enriched heat-stable fraction isolated (modified from Petry 
et al., 2014).  
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Heat-stable fractions were adjusted for protein content as established by a bicinchoninic 
acid (BCA) colourmetic protein assay (Sigma, Dorset, UK) before mixing with lithium 
dodecyl sulfate (LDS) loading buffer containing 15 mM  dithiothreitol (DTT). Samples were 
boiled at 70oC for 10 mins, separated on 4-12 % Bis-Tris Nupage gels (Invitrogen, Paisley, 
UK), immunoblotted on 0.45 µm pore nitrocellulose membranes. Membranes were 
blocked for 1 hr in Tris-buffered saline with Tween (TBST: in mM 50 Trizma base, 150 NaCl, 
0.5% Tween-20), containing 5 % bovine serum albumin or 5 % milk powder for phospho 
and non-phospho sensitive antibodies, respectively. Membranes were incubated overnight 
(4oC) in primary antibodies (HT-7, Pierce, AT-5, Abcam, AT-8, ThermoFisher Scientific, PHF-
1 and CP-13, generous gifts from Prof. P. Davies) and for 1 hr in secondary antibody (goat-
anti mouse, Millipore, 1:5000) at room temperature. Western blots were visualised via 
enhanced chemiluminescent substrate (Tris-HCl, 1.25 mM luminol, 30 µM coumaric acid, 
0.015 % H2O2) and captured with a Vilber-Fusion camera (Fusion Spectra software FX).  
For insoluble-enriched fractions, pellets were homogenised twice in Igepal lysis buffer 
(1ml), spun at 14000 rpm for 20 mins at 4oC, supernatants discarded, prior to incubation of 
remaining pellet overnight at 4 oC, in 1:1 (W/V) 70 % formic acid (Sigma). Following 
incubation, samples were again spun at 14000 rpm for 20 mins at 4 oC, before the 
supernatant was collected and neutralised with 4x neutralising buffer (2 M Tris + 2 M 
NaH2PO4) and treated as above with LDS and DTT and boiling.   
Densitometric blot analysis was conducted using 16 bit image analysis with ImageJ; 
quantification for each sample was normalised for protein loading by re-probing 
membranes for total Tau as detected by the AT-5 pan Tau antibody (1:5000, Abcam). 
Values were normalised cf. PLBWT and pooled for each genotype (PLBWT or PLB2Tau). 
Statistical significance was established via 2-tailed Student’s t-tests between selected data 
pairs. 
Behavioural characterisation 
Unless stated, all cohorts used for behavioural tests were of mixed gender and genotypes, 
and closely matched for age (±4 weeks).  
Spatial Learning (Open Field Water Maze) 
Spatial learning was investigated in PLBWT (6-month: n=19, 12-month old: n=14), and 
PLB2Tau (6-month: n=19, 12-month: n=16) mice with the well-established open field water 
maze (WM) paradigm (see Platt et al., 2011; Ryan et al., 2013; Plucińska et al., 2014). Using 
a white Perspex water filled pool (150 cm diameter, 50 cm in height, water temp 21±1oC), 
animals were allocated a fixed platform position (rising platform, Ugo Basile, Varese, Italy)  
and released from one of four sites along the edge of the pool, (N,E,S,W) in pseudo-
random fashion. Initially, all mice performed a 1 day visible platform test with curtains 
drawn around the pool to obscure spatial cues  (4 trials, 90 sec maximum trial duration, 30 
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min inter trial interval (ITI))  to ensure that mice had intact visual ability. This was followed 
by 4 days of spatial reference training to a submerged platform (4 trials per day, 90 sec 
maximum swim duration,  30 min ITI, no curtains ). A probe trial (60 sec duration, no 
platform) was performed 1 hr post acquisition. Swim paths of all trials were recorded via 
an overhead camera and Any-Maze tracking software (Ugo Basile). Path length and swim 
speed were analysed for visible and spatial learning trials and time in pool quadrants for 
probe trial.  Mean path lengths per training day were compared via a 2-way repeated 
measures ANOVA (day and genotype as variables) and the probe trial analysed via one 
sample t-tests comparing mean % time in target quadrant to chance level (25 %).  
Spatial Corner Learning (IntelliCage) 
The spatial learning abilities were further determined using the IntelliCage system (New 
Behavior, TSE-Systems Bad Homburg, Germany) as previously described (Ryan et al., 2013; 
Robinson and Riedel, 2014). Female mice, 6 (PLBWT: n=10 and PLB2Tau: n=10) and 12-month 
old (PLBWT: n=15 and PLB2Tau: n=13) were implanted with a unique radio transmitting 
microchip (Planet ID, New Behaviour) which enabled tracking and identification of 
individuals as they entered the experimental corners. Mice were given a 2 day habituation 
period, during which water was available in all corners. The number of visits to each corner 
was recorded for each mouse, thus establishing baseline corner visiting behaviour and any 
pre-training corner preference. During the 12 hr test period (conducted in the dark phase), 
individuals were assigned a single corner in which water could be obtained, all other 
corners could be entered but water was not available.  By monitoring the specific corner 
visits of each mouse, relative to total corner visits over the 12 hr time period, learning of 
spatial location for water access was quantified. In 6-month old PLBWT and PLB2Tau, a 
reversal learning paradigm was conducted following spatial learning, whereby the spatial 
location of the water supplying corner was switched to the opposite corner for a 12 hr test 
period and corner visitations recorded. Learning was determined by one sample t-test of % 
corner visits to the hypothetical chance value (25 %) for each genotype. Additionally two 
tailed Student’s t-test comparisons were conducted between genotypes.   
Social Transmission of Food Preference 
Prior to testing, all mice were evaluated for intact basic olfaction using a buried cookie test 
(see Plucińska et al., 2014 for details). For social transmission of food preference (STFP), a 
food bias was induced in an “observer” mouse via a social interaction with a 
“demonstrator” mouse (previously, exposed to the cued food). This test of olfaction-based 
semantic-like memory, was conducted with 6-month old PLBWT, and PLB2Tau mice (n=21 
and 13, respectively). The paradigm consisted of 4 sequential phases: i) Habituation (3 days 
within PhenoTyper cages, water and food ad libitum), ii) assessment of food jar spatial 
location preference (24 hr period), iii) social interaction (SI) with the demonstrator mouse 
and iv) memory test. Prior to SI all mice were food deprived for 16 hrs. Demonstrator mice 
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were exposed to cued food flavours (1 % cinnamon or 2 % cocoa) for 30 mins, before being 
placed in SI cylinders within the observer's cage for 30 mins. SI activity was monitored 
(time spent within a pre-determined interaction zone). Following the SI phase, 
demonstrator mice were removed and after a delay of 15 mins (short-term memory test: 
STM) and 24 hrs (long-term memory test: LTM), the observer mice were presented with 
two food jars (cued and novel). Principle measurements of food intake (in grams) for 
correct and incorrect preference were calculated for both STM (duration: 30 min) and LTM 
(duration: 16 hr). A significant bias for cued food flavour (% cued food) was taken as an 
index of intact semantic-like memory.  Comparison of food intake (correct vs. incorrect and 
between genotypes) was conducted via two tailed Student’s t-tests and food bias 
determined by comparison of food preference to chance level (50%) via a one sample t-
test.     
Elevated Plus Maze 
Assessment of anxiety in 6-month old PLBWT (n=14) and PLB2Tau (n=10) mice was performed 
using the elevated plus maze (EPM) as described by Plucińska et al. (2014). Briefly, mice 
were placed into the central area of the maze (42 cm elevated grey cross-shaped Perspex 
apparatus; arms: 35 cm long × 5 cm wide; central square: 5 × 5 cm, closed arms enclosed 
by vertical walls and open arms with unprotected edges). Time spent within the three 
zones of the arena (open arms, closed arms and centre) during a 5 min exploration period 
was recorded by an overhead camera using Ethovision (V3.1 Plus) tracking software 
(Noldus IT, Wageningen, Netherlands). Comparisons between genotypes were made using 
two tailed Student’s t-tests. Time spent in closed arms of the arena was used as an index of 
anxiety. 
Sucrose Preference Task (IntelliCage) 
Pleasure-seeking behaviour (hedonia) was evaluated in 6-month old PLBWT and PLB2Tau 
female mice (n=10 for both) by a sucrose preference task conducted in the IntelliCage 
system. Mice, implanted with microchips (as in spatial corner learning), were habituated to 
the IntelliCage for 2 days (water available in all corners), followed by 3 test days where 
water could be obtained from two  corners and a 1% sucrose solution was available in the 
other two corners. The number of entries and licks performed in the sucrose and water 
corners was taken as a measure of preference. Bias for sucrose corner visits/licks were 
assessed by comparing sucrose offering corner visits (%) to chance level (50%, one sample 
t-test). Further genotype differences were probed via a 2-way repeated measures ANOVA 
(day and genotype as variables for corner visits and licks and genotype as variables for 
mean licks over the 3 day test period). 
Motor Coordination  
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The sensory motor coordination of 14-month old PLBWT and PLB2Tau cohorts was tested 
using the balance beam as previously described (Robinson et al., 2013).  PLBWT (n=12) and 
PLB2Tau (n=13) mice were tested for latency to traverse beams of varying diameter (28, 11 
or 5 mm) and shape (square or round). All beams were 50 cm in length with a 30% incline. 
Each mouse was given two trials per beam (maximum duration 30 sec) and the latency to 
reach the top end was averaged. Differences in motor coordination for squared or rounded 
beams were established via 2-way repeated measures ANOVAs, with genotype and beam 
diameter as variables; post-hoc Bonferroni tests compared the genotype performance at 
individual beam diameters. 
Activity and Circadian Rhythm  
Using the PhenoTyper homecage system (Noldus IT, Wageningen, Netherlands), 
parameters relating to novel environment habituation, exploratory behaviour and 
circadian activity patterns were measured in 6-month old mice (PLBWT n=12, PLB2Tau n=13), 
as previously described (Robinson et al., 2013; Plucińska et al., 2014). Mice were singly 
housed and given 2 days of habituation prior to assessment of circadian activity (days 3 -7). 
Novel environment habitation was measured as distance moved (extracted in 10min bins) 
for the initial 3hrs following placement in the PhenoTyper. Over the following experimental 
days, distance moved was extracted (in 1 hr bins) across all days to determine exploratory 
and circadian phasic activity over the 24 hr cycle and 12 hr light-dark periods. Habituation 
data were fitted for one-decay non-linear regression analysis.  Comparison of fit was first 
employed to determine significant differences, before individual comparisons of the initial 
activity levels (Y0), activity decay rate (K) and post-habituation activity (plateau) were 
performed.  All data from the subsequent 4 day recording period was probed for significant 
differences by means of repeated measures 2 way ANOVA with genotype and time as 
variables. 
Electroencephalogram (EEG) assessments  
A subset of mice (6-month old PLBWT n=6 and PLB2Tau n=5) underwent surface EEG 
recordings during the PhenoTyper paradigm as described previously (Platt et al., 2011; 
Jyoti et al., 2015). Mice were implanted with epidural electrodes above the left and right 
parietal cortex/dorsal hippocampus (mm relative to Bregma; anterior-posterior axis: +2, 
medial-lateral axis: ±1.5), the right medial prefrontal cortex (mm relative to Bregma; 
anterior-posterior axis: +2, medial-lateral axis: +0.2) and reference/ground electrodes 
placed at neutral locations. Following post-surgery recovery, a 24 hr EEG recording was 
captured via a wireless EEG device (Neurologger, New Behaviour, Switzerland) on the 3rd 
day of home cage activity recorded in the PhenoTyper (200 Hz sampling, band pass filters: 
high pass: 0.25 Hz, low pass: 70 Hz). Animal movement was detected via a built-in 
accelerometer. All data were exported to a PC and converted using EEG Process (Matlab 7, 
The MathWorks Inc., Natick, USA) before imported into SleepSign (Kissei Comtec Co. Ltd, 
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Nagano, Japan) for analysis of vigilance staging (Wakefulness (wake), REM and NREM 
sleep) and power spectra extrapolation (from 4 sec epochs). EEG spectra were determined 
using Fast Fourier Transform (FFT; 0.77 Hz resolution, Hamming window smoothing), 
averaged and normalised to peak as in previous studies (Platt et al., 2011; Jyoti et al., 
2015). For vigilance staging, spectral EEG characteristics of each epoch were classified as 
NREM, REM or wake based on accelerometer activity and parietal/hippocampal spectral 
power (delta and theta power). Time spent in different vigilance stages were calculated (in 
%) during a 4hr diurnal (sleep phase: 10:00-14:00hrs) and nocturnal (activity phase: 22:00-
02:00hrs) period. Statistical comparison employed two way ANOVAs (with state and 
genotype as variables for vigilance stage and genotype and spectral bands as variables for 
power spectra), individual comparisons between genotypes were evaluated by post-hoc 
Bonferroni tests. Spectral bands were defined and illustrated as delta (δ; 1.5–5 Hz), theta 
(θ; 5–9 Hz), alpha (α; 9–14 Hz), beta (β; 14–20 Hz) and gamma (γ; 20–30 Hz). 
Hippocampal Slice Electrophysiology 
Slice preparation and electrophysiological recordings were made as previously reported 
(Platt et al., 2011; Koss et al., 2013). In brief, terminally anaesthetised PLBWT  and PLB2Tau  
mice (6, 12 and 24-month old) were decapitated, brains removed and hippocampi 
dissected in ice cold sucrose-based artificial cerebrospinal fluid (aCSF, mM: 249.2 sucrose, 
1.5 KCl, 1.3 MgSO4, 0.96 CaCl2, 1.5 KH2PO4, 2.89MgCl2·6H2O, 25 NaHCO3 and 10 glucose, pH 
7.4, gassed with 95% O2 / 5% CO2).  Hippocampal slices (400 µm) were stored for at least 1 
hr before use in oxygenated, 32oC, standard aCSF (composition as above, except the 
replacement of sucrose with 129.5 mM NaCl and increased CaCl2 concentration of 2.5 
mM). CA1 field excitatory postsynaptic potentials (fEPSPs) were stimulated by monopolar 
stimulation electrodes (WPI, UK, 0.5 MΩ) positioned in the Schaffer collateral/commissural 
fibres and recorded from the stratum radiatum via aCSF filled borosilicate glass electrodes 
(3-7 MΩ). Captured signals were amplified by a CV203BU preamplifing headstage (gain of 
1, Axon Instruments) and an Axoclamp 200B amplifier (Axon Instruments), before being 
digitized (CED 1401 Plus, Cambridge Electronic Design, Cambridge, UK) and acquired with a 
PC running P-WIN software (Leibniz Institute for Neurobiology, Magdeburg, Germany). For 
the generation of input/output curves (I/O) of basal synaptic transmission, stimulation 
intensity was increased stepwise, until field excitatory post-synaptic potential (fEPSP) 
saturation was achieved (2.5-40 V; 2.5 V increments). For long term potentiation (LTP) 
experiments, baseline recordings (stimulation intensity: 40-50 % of fEPSP maximum, 30 sec 
inter-stimulus interval) were made for 10 mins prior to theta burst tetanus stimulation (5 
Hz, five bursts of four stimuli, 100 Hz, inter burst interval: 200 ms for 1 second) which was 
followed by 60 mins of post tetanus stimulation/recordings (as for baseline recordings). 
Only slices that showed a variability of < 10% in baseline recordings were used. For long 
term depression (LTD), the induction was based on a low frequency stimulation protocol 
(900 pulses at 1 Hz).  Measurements of presynaptic release and short-term plasticity were 
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also assessed using a paired-pulse protocol (stimulation intensity: 60% of EPSP saturation 
inter-stimulus intervals: 10, 20, 40, 100 and 200 ms). 
For I/O curves, fEPSP slopes were pooled for genotype and age, expressed as mean values 
and plotted against stimulus intensity (PLBWT: n=37, 40 and 40. PLB2Tau: n=26, 45 and 31 for 
6, 12 and 24-months of age, respectively) as well as against pre-synaptic fibre volley 
(PLBWT: n=11, 10 and 18. PLB2Tau: n=11, 16 and 18 for 6, 12 and 24-months of age). Long-
term plasticity in hippocampal slices (LTP: PLBWT: n=23, 17 and 11. PLB2Tau: n=8, 25 and 10, 
for 6, 12 and 24 months of age and LTD at 12 and 24-months of age, n=10 for both age and 
genotype groups) signals were expressed relative to baseline values and mean values 
probed for differences in post tetanus time course between groups. For paired-pulse 
responses (PLBWT: n=9, 16 and 14. PLB2Tau: n=10, 14 and 9 for 6, 12 and 24-months of age, 
respectively), the second response was calculated relative to the first response (S2/S1). 
Comparisons between groups were made via 2-way ANOVA (genotype/age and 
stimulus/pre-synaptic fibre volley, as variables) for input/ output fEPSP slopes. Post 
tetanus changes were compared via 2-way repeated measures ANOVA (genotype/age and 
time as variables).  
Data Analysis 
Prism Software (V.5 GraphPad, CA, USA) was used for all statistical analyses and data are 
expressed as means + or ± SEM. α was set at 0.05, with p<0.05 being considered 
statistically significant, p<0.01 as highly significant and p<0.001 as extremely significant. 
 
Results 
Confirmation of Construct Expression 
Founder PLB2Tau mice were derived from selective cross-breeding of homozygous PLBDouble 
female mice with heterozygous Cre-recombinase expressing male mice. Successful 
genomic excision of the LoxP-flanked hAPP gene was confirmed in the resulting offspring 
via ear biopsy PCR with a modified HPRT primer set (see methods). Mice expressing only 
the hTau transgene were identified by the production of a 2.6 kb amplification product in 
contrast to the 5.6 kb amplification product derived from the expression of the non-
excised PLB construct (Fig. 1.A+B). Mice identified as hemizygous PLB2Tau males and 
heterozygous PLB2Tau females were then crossed to produce a homozygous line for 
subsequent breeding. All further analysis was conducted on homozygous / hemizygous 
offspring. 
The regional transgene specificity provided by the CaMKIIα promoter was confirmed in 12-
month old PLB2Tau mice via quantitative PCR (Fig. 1.C). Forebrain samples, probed with 
hTau specific primers, yielded a ~10 fold increase in PCR product levels over those 
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detected in cerebellum samples from the same mice (p<0.001, n=5). No amplification 
product was detected in PLBWT samples. Transgene expression was ~24-fold below that of 
endogenous murine Tau levels, established in PLBWT mice (p<0.001, data not shown). 
hTau Protein Expression and Tau phosphorylation 
Forebrain tissue analysis confirmed the expression of FTD mutant hTau. Despite the low 
RNA yield of the PLB2Tau transgene, hTau protein was robustly detected in heat-stable 
extracts in samples from 6- and 12-month old PLB2Tau mice (HT-7 immunoreactive band 
migrating at 60kDa, Fig. 2.A+B). No corresponding immunoreactive signal was observed in 
any of the PLBWT samples. Comparison between 6- and 12-month old PLB2Tau samples 
suggested a relative reduction in the abundance of hTau in the soluble fraction of forebrain 
lysates with age (Fig 2.B, p=0.07, respectively). Overall Tau protein expression (pooled pan 
Tau AT-5 immunoreactive bands, corresponding to ~50 kDa: 0N4R, ~55 kDa: 1N4R and ~60 
kDa: 2N4R adult Tau isoforms, McMillan et al., 2008), was not altered relative to age-
matched controls at 6 or 12-months of age (Fig. 2.A+C, p>0.05), likely due to the unaltered 
levels of the major 50 kDa species. When considered independently, modest but significant 
increases in levels of 55 and 60 kDa Tau species were observed in PLB2Tau mice at 6- and 
12-months of age (Fig. 2.A+D+E).  Together, the data verify the successful expression of the 
hTau transgene in PLB2Tau mice and further demonstrate an increase of endogenous 
murine Tau (55 kDa band). Preliminary investigations into the levels of insoluble Tau with 
matching samples suggested no difference between genotypes (data not shown). 
Enhanced Tau phosphorylation at the PHF-1 epitope (Ser396/Ser404) was observed in 
brain lysates from 6-month (Fig. 3.A+B, p<0.01) and 12-month old PLB2Tau mice (Fig. 3.A+B, 
p<0.001) relative to corresponding PLBWT samples when tested at 7.5 µg protein/lane. 
Further analysis of the individual bands demonstrated an age-dependent progression of 
phosphorylation at the PHF-1 epitope in the PLB2Tau mice, such that at 6-months of age, 
only the 50 (Fig. 3.C, p<0.01) and 55 kDa (Fig. 3.C; p<0.05) phospho-Tau species were 
elevated (Fig. 3.A+C), yet by 12-months of age, all Tau species demonstrated robust 
increases (Fig. 3.A +D, p<0.05).  Similar changes in Tau phosphorylation were observed for 
the CP-13 (Ser202) epitope, when pooled (Fig. 3.E +F) or as individual Tau species (Fig. 
3.E+G+H).  Additionally, a subtle but significant increase in the phospho-epitope AT-8 signal 
was observed for both 6 and 12-month old PLB2Tau samples (Fig 3.I; p<0.05 and p<0.01 for 
6 and 12 month old PLB2Tau samples respectively). Note that 15 µg as oppose to 7.5 µg of 
protein per lane was required in order to visualise all tau immunoreactive bands. As for the 
previous epitopes, the 50 kDa migrating band was elevated at 6 months of age relative to 
PLBWT samples (Fig 3.K; p<0.05) and increased 60 kDa immunoreactivity emerged by 12-
months of age (Fig 3.L; p<0.05). 
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1) Behavioural characterisation: Learning and memory 
a) Spatial Reference Memory: Open Field Water Maze 
Assessment of spatial learning and memory was initially conducted in the established 
hippocampus-dependent water maze (WM) paradigm. Intact visual acuity was confirmed 
in PLB2Tau mice; no effect of age or genotype were observed during the visible platform 
test (p>0.05, data not shown). Spatial acquisition in PLB2Tau mice at either 6 or 12-months 
of age was intact (Fig. 4.A+D, genotype effect: p>0.05 for both age groups), and neither 
genotype presented with age-related changes (p>0.05). Only accelerated swim speeds 
compared with PLBWT mice were observed at 12-months (Fig. 4.D, PLB2Tau: F(1,112)=25.56, 
p<0.001) but not at 6-months of age (Fig. 4.B). In agreement with acquisition performance, 
spatial retention during probe trials indicated that all groups displayed a preference for the 
trained quadrant (Fig. 4.C+F, p<0.05 cf. chance, for all).  
b) Corner Learning and Reversal 
Spatial learning and memory was further probed in the Intellicage via a water rewarded 
corner learning paradigm. At 6-month of age, PLBWT mice acquired a preference for the 
water corner during the spatial learning (Fig. 5.A, p<0.05 cf. chance). In contrast, PLB2Tau 
failed to attain a spatial bias (p=0.05 cf. chance). Notably, comparison of total corner visits 
performed by each group across the habituation and test phases indicated a prominent 
hypo-active phenotype in the PLB2Tau mice (Fig. 5.B: F(1,18)=10.02, p<0.01).  
The 6-month cohort was further tested in a reversal learning paradigm. Both groups 
displayed a significant corner preference above chance (Fig. 5.A, PLBWT=47.7±2.7% p<0.001 
and PLB2Tau=35±4.2%, p<0.05), however PLB2Tau mice displayed a reduced preference for 
the reversal corner relative to controls (p<0.05). In addition, a trend towards a hypoactive 
phenotype in the PLB2Tau mice was again observed (fewer total corner visits compared to 
controls; Fig. 5.B, p=0.06).   
At 12-months of age PLB2Tau mice demonstrated a clear impairment in spatial learning and 
failed to acquire a preference for the water corner (Fig. 5.C, PLB2Tau; p>0.05, cf. chance). 
The performance of PLBWT mice was unaffected by age (corner preference p<0.001, cf. 
chance; effect of age p>0.05). Similar to observations at 6-month of age, PLB2Tau mice 
continued to display hypoactivity with a reduced number of total corner visits (Fig. 5.D, 
genotype effect p<0.05). 
c) Social Transmission of Food Preference 
Next, semantic-like memory of 6-month old PLBWT and PLB2Tau mice was assessed. As STFP 
is dependent on olfaction and social motivation, all mice were initially evaluated for 
comparable performances in the cookie test and SI phase of the STFP paradigm.  No 
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significant genotype effect was observed in the cookie test (p>0.05, data not shown) or 
during the SI phase (time spent in proximity of demonstrator mouse, p>0.05, data not 
shown). A robust preference for the correct (cued) food was detected in PLBWT mice 
following a 15 min delay (Fig. 6.A, STM; p<0.01) and 24 hr delay (Fig. 6.A, LTM; p<0.001). In 
contrast PLB2Tau mice failed to display such a preference independent delay (Fig. 6.A, 
p>0.05 for both STM and LTM) and consumed less of the correct food (PLB2Tau cf. wild-type 
mice: p<0.05 and p<0.001 for STM and LTM, respectively). Total food intake during either 
of the test phases was not different between genotypes (p>0.05 for all, data not shown). 
The semantic memory impairment was further confirmed when food preference was 
considered as % of total intake (Fig. 6.B, PLBWT p<0.001 cf. 50% chance for STM and LTM, 
PLB2Tau: p>0.05 cf. chance for STM and LTM). 
2) Non-cognitive Phenotypes 
a) Anxiety 
In addition to memory impairments, FTD often presents with a range of emotional 
alterations. Anxiety was investigated at 6 months of age using the EPM in PLBWT and 
PLB2Tau mice.  The EPM was highly anxiogenic independent of genotype; all mice spent the 
vast majority of time in the closed arms of the maze (Fig. 7.A, 84.9±2.4 % for PLBWT and 
91.6±1.3 % for PLB2Tau mice). A slight, yet significant increase in time spent in the closed 
arms was observed in PLB2Tau mice, alongside a corresponding reduction in the time spent 
exploring the open arms of the maze (p<0.05). 
b) Anhedonia 
Additional 6-month old cohorts were tested for pleasure seeking behaviour (hedonia) by 
exploiting the natural preference of mice for sweet food sources.  When analysed over the 
entire 72 hr observation period both PLBWT and PLB2Tau mice displayed a strong preference 
for visiting sucrose corners over those containing water (p<0.001, cf. chance level); 
however, the overall preference for sucrose corners was reduced in PLB2Tau mice. Initially, 
PLB2Tau mice demonstrated no preference, but gained preference for the sucrose corner 
from day 2 (Fig. 7.Bi, Day 1: p>0.05, day 2:  p<0.05, day 3: p<0.001).  In contrast, PLBWT 
mice strongly opted for the sweetened water across all experimental days. 
Correspondingly, an effect of genotype (F(1,36)=14.55, p<0.01), day (F(2,36)=3.771, p<0.05) 
and an interaction (F(2,36)=19.8, P<0.001) were observed. Sucrose preference was further 
corroborated by the number of licks (Fig. 7.B ii) with an effect of drinking solution 
(F(1,18)=541.3; p<0.001) and an interaction with genotype and drinking solution 
(F(1,18)=22.76; p<0.001). PLBWT and PLB2Tau mice displayed a greater number of licks in the 
sucrose corner compared to chance (p<0.001 for both).  However, PLB2Tau mice licked less 
cf. controls in the sucrose corner and more in corners containing water (p<0.001). Fewer 
total visits in the PLB2Tau mice compared to PLBWT were recorded, which again suggests a 
16 
 
 
hypo-active phenotype at 6-months of age; yet this did not reach significance (genotype 
effect: p=0.07).   
3) Movement, Exploration and Vigilance  
a) Motor Coordination 
The reduced number of corner visits performed by PLB2Tau mice in both spatial learning 
and sucrose preference paradigms may indicate motor dysfunction, hence, 14-month old 
mice were evaluated in the balance beam paradigm. No impairment in performance was 
detected for any beam diameter or shape (Fig. 8 A+B). In fact, PLB2Tau mice performed 
somewhat better as indicated by lower traverse latencies in the least challenging diameter 
of the square beam test (interaction: F(2,46)=6.142: p<0.01, post-hoc analysis p<0.01 for 28 
cm diameter). 
b) Circadian Activity and Exploratory Locomotion 
Investigations of ambulatory activity of 6-month old PLB2Tau mice had demonstrated 
overall reduced activity, notable in each parameter studied. In the PhenoTyper, PLB2Tau 
mice demonstrated lower exploratory activity during the habituation phase compared with 
age matched PLBWT mice (F(1,340)=5.39, p<0.05, Fig. 9.A). A one phase decay non-linear fit of 
habituation data (considering Y0, plateau and K) indicated that the activity curves over the 
180 min period were significantly different between genotypes (p<0.001), with faster 
kinetics in the transgenic group. However, considered individually there were no 
differences in the initial activity (Y0), the final baseline activity following habituation 
(plateau) or the rate at which activity declined (K).  
Following the habituation phase, evidence for reduced exploratory activity persisted over 
time (genotype: F(1,2093)=16.64, p<0.001, Fig. 9.B) as well as for the mean activity per hour 
over a 24 hr cycle (F(1,552)=16.2, p<0.001, Fig. 9.C), the activity of PLB2Tau mice being 
particularly diminished during the initial hours of the dark phase. However overall a 
significant effect of genotype was observed for pooled mean light and dark phase activity 
(F(1,25)=12.89, p<0.01, Fig. 9.D) and post-hoc analysis indicated decreased activity during 
both phases in PLB2Tau mice (light and dark, p<0.01).   
c) Vigilance states and EEG recordings 
The preceding data suggested a reduction in activity independent of day/night phase. 
However, quantification of EEG-guided vigilance stages during PhenoTyper recordings in 6-
month old cohorts demonstrated that transgenic mice were in fact more awake, and 
significantly so during the light (rest) phase, despite the reduced motor activity. A selective 
disruption of sleep stages was confirmed only during the light (rest) phase (vigilance 
composition:  state: F(27,2)=1534, p<0.001 and interaction: F(2,27)=47.02, p<0.001), when 
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PLB2Tau mice spent an increased time awake (Fig. 10.A, p<0.001) and correspondingly a 
decreased time in NREM (p<0.001).  Nocturnal vigilance states were unaffected (Fig 10.A).  
Spectral analysis of EEG recording from both hippocampal and prefrontal regions 
demonstrated overall significant interactions for both spectra during wakefulness (F>1, df= 
380, p<0.05), largely due to a loss in alpha power in both frontal and parietal locations. 
During sleep, however, region- and stage-specific changes were also detected: REM 
spectra were overall affected only in the parietal channel, while NREM spectra differed 
only in the prefrontal location (effects of genotype and interaction for both: p<0.001). The 
most apparent change in the REM spectrum was an increase in delta power, while the 
prefrontal NREM spectrum was globally affected (see Fig. 10.B for full statistical band 
analysis). 
 
 
d) Hippocampal Electrophysiology 
Given the rather modest impairments of PLB2Tau in hippocampus-dependent tasks yet 
altered parietal EEG profiles, hippocampal slice electrophysiology was investigated for 
further evidence of intact vs. impaired hippocampal signalling. Initial input/output (I/O) 
curves generated for stimulation input vs. fEPSP slope indicated that basic hippocampal 
synaptic transmission was unaltered in PLB2Tau slices compared with PLBWT slices at 6 and 
12-months of age (Fig. 11.Ai + Aii, p>0.05 for both). However, an overall reduction in the 
evoked fEPSP slope across the stimulation range was observed at 24 months of age (Fig. 
11.Aiii, genotype: F(1,1104)=28, p<0.001). Evoked fEPSP slopes were also plotted against fibre 
volley amplitudes, indexing the degree of pre-synaptic depolarisation required to evoke 
postsynaptic depolarisation (Koss et al., 2013). Here, I/O curves demonstrated reduced 
presynaptic efficiency in eliciting postsynaptic depolarisation at all ages in PLB2Tau 
preparations compared to WT counterparts (Fig. 11.B: 6-months: F(1,280)=6.072, p<0.05, 12-
months: F(1,240)=7.169, p<0.001 and 24-months of age: F(1,340)=29.53, p<0.001).  An 
age−dependent decline in pre- / post- synaptic efficiency was present in both PLBWT and 
PLB2Tau mice (age effect: WT: F(2,440)=14.87, p<0.001 and PLB2Tau: F(2,420)=23.09, p<0.001). 
Paired analysis between age groups indicated that the most pronounced deficit occurred 
from 12 to 24 months of age (p<0.001). 
LTP was not significantly affected in PLB2Tau hippocampal slices at any age tested, despite 
reduced synaptic efficiency. However, at 12 months a strong trend for impaired LTP in 
PLB2Tau mice was observed (Fig. 11.C, F(1,2242)=3.394, p=0.07). Further protocols for LTD and 
paired-pulse facilitation/ inhibition did not yield any alterations between WT and PLB2Tau 
mice (data not shown). 
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Discussion 
We here report on a novel low-expression hTau knock-in model of FTD, the PLB2Tau mouse, 
which recapitulates key aspects of FTD. Phenotypically, PLB2Tau mice demonstrated 
disturbances in emotionality and pronounced semantic memory deficits alongside altered 
activity and vigilance yet only modest spatial learning deficits. Corresponding impairments 
in neuronal physiology revealed shifts in EEG power spectra and hippocampal transmission 
efficiency, while hippocampal synaptic plasticity was largely preserved. Functional 
disruptions emerged alongside increased tau phosphorylation without overt tau 
aggregation. 
 
Emotional Phenotypes of PLB2Tau mice 
The most striking changes observed in PLB2Tau mice relate to non-cognitive behavioural 
abnormalities evident in a number of emotional and motivation measures. Emotional 
disturbances in FTD patients comprise aberrant social behaviour, anxiety, apathy and 
disinhibition (Zamboni et al., 2008; Perri et al., 2014), which may correlate with prefrontal 
vs. temporal atrophy. PLB2Tau mice demonstrated heightened anxiety indicated not only by 
their behaviour within the EPM, but evident throughout all behavioural tests, such as 
decreased exploratory behaviour in the PhenoTyper, reduced corner visits in the 
IntelliCage and elevated swim speeds in the WM. This is in contrast to the unaffected 
anxiety levels or indeed the bold non-anxious behaviour described in many other FTD 
models (see Table 1). Such data have been interpreted as disinhibition, also frequently 
reported in FTD cases (Tanemura et al., 2002, Takeuchi et al., 2011). Here, the PLB2Tau mice 
demonstrated both elevated anxiety and traits of apathy and/or depression (anhedonia 
and reduced consumption of food and liquid provisions). Several clinical studies have 
indicated a high prevalence of anxiety in human FTD, (~50%, Porter et al., 2003, Chiu et al., 
2006; Tartaglia et al., 2014), and stratification of the disease suggests comorbid depression 
in those FTD cases where anxiety is prominent (Mourik et al., 2004). Ultimately, it is 
difficult in mice to dissociate a depressive phenotype from one of apathy, frequently 
encountered early in FTD (>80%; Malloy et al., 2007; Rascovsky et al., 2011). In any case, 
emotional behaviour is often insufficiently determined in transgenic mice, but it is 
interesting to note that human symptoms correspond well to the apathetic (under 
undisturbed conditions) yet anxious (under stressful conditions) behaviour of PLB2Tau mice. 
The few studies which investigated the emotional phenotypes of FTD tau models describe 
decreased reward-seeking behaviour and increased forced swim test immobility, which 
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correlated with a diminished basal serotonergic tone within the frontal cortex (Egashira et 
al., 2005; Van der Jeugd et al., 2013).  
Potentially as a result of altered emotionality, PLB2Tau mice demonstrated a robust 
hypoactive trait in many experimental parameters, most evident when monitoring 
circadian and ambient activity within the PhenoTyper. In this respect PLB2Tau mice present 
a similar global reduction in activity as observed in human FTD (Harper et al., 2001; 
Anderson et al., 2009). Hypoactivity and inertia  being most pronounced during the initial 
waking hours, which was also observed here in PLB2Tau mice. Hypoactivity was present 
without any overt motor deficits, which are often confounding factors in many models with 
high tau expression (see Table 1). Even in models employing forebrain specific promoters 
(Santacruz et al., 2005), a loss of cortico-spinal neurons coincided with the progressive 
emergence of motor deficits, yet here as well as in other low expression models 
(Tatebayashi et al., 2002) such impairments could be avoided.  Instead, the reduced 
exploratory activity in addition to the more rapid habituation may index a state of apathy 
or anxiety (Salomons et al., 2010). Furthermore, increased wakefulness and a reduction in 
NREM sleep of the PLB2Tau mice rule out increased sleep time as the reason for reduced 
exploratory activity. In this respect, PLB2Tau mice present a highly FTD relevant phenotype 
as sleep disturbances are common in all dementias (Guarnieri et al., 2012), with reduced 
sleep duration commonly reported in FTD cases (Bombois et al., 2010; Bonakis et al., 
2014). 
Distinct cognitive deficits of PLB2Tau mice 
Though behavioural and emotional disruptions typify FTD symptomatology, cognitive 
deficits are also key symptoms. Well established are semantic memory problems, which 
present during the early manifestations of FTD, particular in those cases diagnosed as 
svFTD (Rogers et al., 2006; Rascovsky et al., 2007). Corresponding impairments were 
evident in the PLB2Tau mice at 6 months of age in the STFP paradigm. This task depends on 
several behavioural facets, such as sociability, olfaction and semantic memory, with 
neuroanatomical correlates in the pre-frontal and hippocampal regions (Van der Kooji and 
Sandi, 2012). Both sociability and olfaction of PLB2Tau mice were unaltered, yet a 
preference for cued food was not established independent of the delay. 
The deficit in semantic memory was in contrast to intact spatial learning demonstrated in 
the MW of both 6- and 12-months old PLB2Tau mice. Though many previous FTD mouse 
models (including the rTg4510 model which also utilises the forebrain specific CaMKIIα 
promoter) report spatial deficits in acquisition as well as recall (see Table 1), the intact WM 
performance observed here is again in keeping with other models where tau expression is 
low (Tanemura et al., 2002). The absence of robust dysfunction in non-overexpressing 
models is suggestive of a dose-dependent relationship between tau and hippocampal 
impairment. Here, when spatial memory was further assessed in the corner learning 
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paradigm of the IntelliCage, 6-month old PLB2Tau mice presented with only modest 
impairments which marginally progressed in severity with age. The discrepancy in 
performance between the two paradigms may indicate an influence of test parameters on 
performance: The WM utilises repeated temporal exposure to an adverse and stressful 
situation, whilst the IntelliCage exploits innate explorative behaviour and the urge for 
water intake. Together, the impaired learning in the corner learning task suggests reduced 
motivation and exploration (as discussed above), amidst modest hippocampal dysfunction. 
Deficits during IntelliCage testing were however apparent in the reversal learning 
paradigm. The poor performance of PLB2Tau mice may indicate a mild deficit in 
hippocampal function alongside a more prominent dysfunction in prefrontal cortical 
processing, given this region’s involvement in reversal learning (de Bruin et al 1994; Lacroix 
et al., 2002; Murray et al., 2015) and may be relevant for the executive dysfunction and 
stereotyped mental rigidity observed in FTD patients (Bozeat et al., 2000; Stopford et al., 
2012).  
In humans, spatial memory is also commonly preserved in the early stages of FTD, while 
motivational and attentional deficits are often encountered, which reportedly introduce 
confounding factors for various memory tasks (Stopford et al., 2012). Indeed, this profile of 
selective deficits may provide further evidence of the FTD relevant phenotype of the 
PLB2Tau mice, expressing prominent semantic deficits earlier than spatial memory deficits, 
potentially reflecting a vulnerability of higher neuronal processes (semantic vs. spatial 
learning) and regions (prefrontal vs. temporal) relevant to FTD tau pathology. Similar 
findings have been reported in the THY-Tau22 mouse model, where non-spatial memory 
was affected prior to spatial memory, although only a modest reduction in STFP was 
observed (Van der Jeugd et al., 2013) and are in agreement with results in L66 (Melis et al., 
2015) and V337M models (Tamemura et al., 2001).  
Interestingly, we have previously reported deficits in WM acquisition at 12 months and 
corner learning at 4 months in the related PLB1Triple mouse which expresses the same hTau 
transgene alongside mutant hAPP and PS1 (Platt et al., 2011; Ryan et al., 2013), suggesting 
that the IntelliCage may be more sensitive than the WM to detect spatial learning 
impairments. Alternatively as PLB1Triple mice serve as a model of AD, where spatial learning 
impairments are early and defining symptoms of the disease, the divergent cognitive 
phenotypes of PLB2Tau and PLB1Triple mice may highlight differential behavioural traits 
induced by a combination of AD and FTD-Tau familial mutations when compared to FTD-
Tau mutants alone. 
Electrophysiological phenotypes of PLB2Tau mice 
Region-specific physiological changes that may underpin parietal (hippocampal) vs. frontal 
changes were uncovered in in vivo EEG recordings, while hippocampal slice experiments 
confirmed a mild impairment in synaptic transmission only. The most striking changes in 
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EEG spectra were a reduction in alpha power for both brain regions in awake PLB2Tau mice, 
and an increase in delta power during REM sleep specific to the parietal channel. This 
agreed by and large with the phenotype encountered in PLB1Triple mice (Platt et al., 2011). 
However, sleep spectra of PLB2Tau mice showed a much clearer region- and stage-specific 
profile and overall more robust spectral changes, contrasting with subtle and band-specific 
EEG changes of the triple transgenic mice at this age.  
Of the limited work conducted on EEG in FTD patients and FTD models, early observations 
suggest that EEG abnormalities are milder compared with AD, and standard EEG 
parameters may appear normal in FTD amidst altered behaviour and cognition (see 
Micanovic and Pal, 2014 for review). However, the recent adoption of quantitative EEG 
(qEEG) measures has demonstrated reduced power particularly in alpha and beta bands in 
FTD patients (Lindau et al., 2003). Clearly, further studies are required, as this approach 
may provide valuable translational and diagnostic value (Platt & Riedel, 2011; Platt, Welch 
& Riedel, 2011). In particular, novel qEEG parameters and network analyses may offer 
improved disease-specific criteria (Farb et al., 2013; Wessel et al., 2015). 
A correlate of changes in hippocampal power spectra may be found within altered synaptic 
efficiency observed in hippocampal slices from PLB2Tau mice. Here, a reduction in basal 
synaptic transmission emerged early (at 6 months), with only a modest impact on LTP at 12 
months. Intact LTP agrees with sustained WM performance (Whitlock et al., 2006; Nabavi 
et al., 2014), and with the proposition that altered motivation and impaired prefrontal 
processing may have contributed to deficits in other cognitive tasks. Corresponding 
investigations in other transgenic Tau models has yielded diverse and somewhat 
contradictory results, e.g. decreased basal synaptic efficiency in the absence of altered LTP 
(Schindowski et al., 2006), or in combination with impaired LTP (Yoshiyama et al., 2007) or 
impaired LTP only (Rosenmann et al., 2008, Hoover et al., 2010; Van der Jeugd et al., 2012). 
These inconsistencies are likely due to the varying level of transgene expression and 
electrophysiological protocols. Impairments in synaptic physiology may also be dependent 
on the specific FTD tau mutations and the resultant degenerative mechanism (Lee et al., 
2009, Tackenberg and Brandt, 2009). Intriguingly, a reduction in basal synaptic efficacy was 
only observed >12 months in the related PLB1Triple mouse model of AD (Koss et al., 2013) 
while LTP was affected from 6 months onwards, despite the expression of the identical tau 
transgene, again suggestive of transgene-specific yet non-additive degenerative 
mechanisms. 
Transgene Expression and Protein Profiles 
In comparison with many previous hTau models, PLB2Tau mice express low levels of the 
transgene, originating from the single hTau vector knock-in and a region-specific regulatory 
element. This low level was sufficient to induce highly FTD relevant phenotypes. The subtle 
increase in a specific 60 kDa Tau species reported here must be considered crucial as the 
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majority of existing hTau models show overexpression (up to 13 fold of total endogenous 
Tau, see Table 1). Though pronuclear injection derived models can provide robust 
phenotypes with a short pre-symptomatic period, the PLB2Tau model may limit any 
potential confounding pathology derived from Tau overexpression, which could mask 
mechanistic differences between FTD mutant driven Tau dysfunction and those reported in 
animal models from the overexpression of non-mutant hTau (Spittaels et al., 1999; 
Polydoro et al., 2009).  
The single hTau species migrating at 60 kDa (corresponding to the 2N4R isoform, Buee et 
al., 2000) detected here was present alongside an additional elevation of Tau protein at 55 
kDa, indicative of a modest increase in endogenous murine Tau, in agreement with other 
models where endogenous Tau was subject to accumulation, hyper-phosphorylation and 
aggregation (Mocanu et al., 2008, Cowan et al., 2010; Baglietto-Vargas et al., 2014). 
Abnormal elevations in tau phosphorylation at the PHF-1, CP-13 and AT-8 epitopes initially 
affected endogenous murine Tau, most prominently at the major 50 kDa species, but by 12 
months of age progressed to encompass all remaining isoforms. Despite the elevation in 
tau phosphorylation there was no notable shift in electrophoretic migration nor the 
emergence of specific hyperphosphorylated species as reported in human AD cases 
(Flament and Delacourte, 1989) and in several FTD Tau mouse models (Berger et al., 2007; 
Sahara et al., 2013). The evidence present here suggests that elevations in tau 
phosphorylation may be sufficient to driving quantifiable behavioural phenotypes.  
Both P301L and R406W mutations contained within the hTau transgene could contribute 
to the pathogenic mechanism underlying the observed phenotypes. R406W containing 
Tau, alone or in combination with other FTD mutations, has previously been reported to 
lower Tau phosphorylation at some epitopes in both cellular (Gauthier-Kemper et al. 2011) 
and animal models (Lim et al., 2001; Zhang et al., 2004). Such an anomaly is particularly 
evident at the PHF-1 epitope (Ser396/Ser404), as the missense mutation restricts GSK-3β 
kinase accesses (Vogelsberg-Ragaglia et al., 2000). However, in human FTD R406W cases, 
the phosphorylation of the PHF-1 epitope is enhanced, predominantly due to 
phosphorylation of non-mutated Tau in the soluble fraction (Miyasaka et al., 2001). 
Correspondingly, the increase in PHF-1 positive Tau in PLB2Tau mice may reflect the 
progressive phosphorylation primarily of the endogenous murine Tau species.  
The emergence of phospho-tau pathology in the PLB2Tau mouse is an important 
demonstration of tau phospho-pathology without overt overexpression. It is at present 
unclear why the previously generated P301L KI Tau mouse failed to demonstrate cognitive 
deficits and presented with Tau hypo-phosphorylation (Gilley et al., 2012). Increased Tau 
hyperphosphorylation had been consistently reported in conventional P301L models 
(Lewis et al., 2000,  Gotz et al., 2001,  Santa Cruz et al., 2005;  Terwel et al., 2005), hence 
overexpression could be assumed to be a causative factor for such phosphorylation (see 
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Table 1). However, our data argue against this and may suggest that the problem of the 
P301L KI model lies within the substitution of proline with lysine at amino acid residue 290, 
which may not be comparable with the substitution at residue 301 of the human tau gene. 
As both PHF-1 and AT-8 are regarded to detect late stage phospho-epitopes associated 
with NFTs (Augustinack et al., 2002), it is perhaps surprising that no phospho- or total Tau 
was detected within the insoluble fraction of our preparations. However, AT-8 and PHF-1 
immunoreactivity is not exclusively associated with NFTs, as AT-8 positive neuropil threads 
and pre-tangle neurons were detected in human AD cases (Lasagna-Reeves et al., 2012) 
and each epitope is readily detected in soluble tau extracts from tauopathies and animal 
models (see Anderson et al., 2008 and Deter et al., 2008 for examples). Together, our data 
strongly suggest that PLB2Tau mice present with elevated levels of soluble phospho-Tau 
species without the overt presence of insoluble aggregates within the age-range 
investigated. A progressive deposition of Tau may indeed occur later, but the onset of 
behavioural abnormalities correlated with the emergence of elevated soluble Tau 
phosphorylation, in agreement with observations in other Tau models (Berger et al., 2007; 
Flunkert et al., 2013; Koss et al., 2015) and is supportive of the disruption of neuronal 
function associated with soluble tau pathology rather than the presence of aggregated tau 
species (Fox et al., 2011; Polyodoro et al., 2014). The implicated toxicity of soluble 
phospho-tau is further in keeping with the lack of behavioural deficits detected within the 
life-span of P301L KI mice where tau is hypo-phosphorylated (Gilley et al., 2012). 
Conclusions 
PLB2Tau mice express low hTau transgene levels specifically in the forebrain, which yields 
subtle hTau protein expression and phospho-tau pathology that incorporates both murine 
and transgenic tau species.  This drives highly FTD relevant phenotypes related to semantic 
memory, anxiety, anhedonia, sleep and activity, with only mild age-dependent 
impairments in spatial learning. The selective development of electrophysiological, 
behavioural and cognitive changes in PLB2Tau mice highlight the specific vulnerability of 
neuronal networks to tau pathology and associated disruptions in neuronal 
communication.  In particular, the emergence of semantic memory deficit together with 
FTD-relevant emotional disturbances amidst largely preserved spatial memory suggests 
that PLB2Tau mice can serve as a highly relevant model of FTD rather than AD, with a strong 
translational potential.  
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Figure and Table Legends 
 
Table1: Overview of transgenic hTau expressing mouse models. Model name, Tau 
mutation, isoform, promoter, expression level (‘Expression’), regional expression (‘Region’), 
histopathology and behavioural / cognitive phenotypes are shown, and listed in order of 
publication year. For onset, age in months is given either for earliest report of 
histopathology (a) or behaviour (b). For behavioural/cognitive phenotypes, specific aspects 
affected are given in brackets, arrows indicate decline or enhancement.  Abbreviations: B.S. 
= brain stem, CaMKII = Ca2+/Calmodulin Kinase II, CNS = central nervous system, E.C = 
entorhinal cortex, EPM= elevated plus maze, Endo.= endogenous, F.B. = forebrain, L/D box 
=light/dark box,  NFTs= neurofibrillary tangles, N.R. = not reported, OF =open field, P-Tau= 
phospho-Tau, PDGF-β=platelet-derived growth factor β, PrP= prion protein promotor, PPI= 
pre-pulse inhibition, S.C. = spinal cord , STFP = social transmission of food preference, Tet= 
Tetracycline inducible, WM= water maze. [Table 1 – 2 column fit] 
 
Figure 1: PLB2
Tau
 gene construct and transgene expression.  
PLB2
Tau
 mice were derived from PLB1
Double
 mice expressing human APP and human Tau, 
crossed with Cre recombinase expressing mice. A) Genetic construct of PLB1
Double
 mice: the 
CaMKIIα promoter, human APP
770
 gene (hAPP), an internal ribosome entry site (IRES) and 
the human Tau 2N4R gene (hTau) are shown. hAPP and hTau genes were flanked by LoxP 
and FRT excision sites, respectively. The PLB2
Tau
 construct resulting from the crossing of 
PLB1
Double 
mice with Cre recombinase mice is also depicted, where only the hTau gene 
remained.  The product size of PCR amplification from a modified HPRT locus primer set is 
also illustrated.  B) PCR confirmed the expression of the PLB1
Double 
HPRT construct (5.2 kb) 
or the PLB2
Tau 
HPRT construct (2.6 kb) in PLB1
Double
 (PLB1) and PLB2
Tau
 (PLB2) mice, 
respectively. PLB
WT
 and H
2
O samples were included as negative controls. C) Regional 
transgene mRNA expression in 12-month old PLB2
Tau
 forebrain and cerebellum samples 
were established by hTau specific RT-PCR. Predominant gene expression within the 
forebrain was confirmed. Mean data are expressed relative to the GAPDH house-keeping 
gene (+ SEM). ***=p<0.001.  [Figure 1 – 1 column fit] 
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Figure 2: Tau protein expression in PLB2
Tau
 mice.   
A) Successful translation of the expressed hTau transgene was confirmed in heat-stable 
forebrain lysates from PLB2
Tau
 mice (6 & 12-months of age) by immuno-blot detection. A 
single 60 kDa protein band (human specific HT-7 Tau antibody), was evident in all PLB2
Tau
 
mice lysates, in contrast no signal in PLB
WT 
was detected, despite endogenous Tau 
detection via the AT-5 Tau antibody.  B) Quantification of hTau expression relative to total 
Tau at 6 and 12 months demonstrated a trend for an age-dependent decline in hTau levels 
(p=0.07). C) No overall increase of total Tau was observed relative to age-matched PLB
WT
 
mice in both age groups. D) Individual analysis of each Tau (AT-5 positive) band revealed 
significant increases in the levels of 55 and 60 kDa Tau species in 6 month old PLB2
Tau
 mice 
relative to PLB
WT 
controls (n=14 for both). E) Similar results were confirmed for PLB2
Tau
 
mice at 12 months of age. Data were normalised to either 6 months PLB2
Tau
 samples for 
age comparison (B) or to age-matched PLB
WT
 
mice (C-E) for total Tau expression and 
presented as mean +SEM. *=p<0.05 and **=p<0.01.  [Figure 2 – 2 column fit] 
 
Figure 3: Phospho-Tau expression in PLB2
Tau
 mice.   
A) Heat-stable forebrain lysates from PLB
WT
 and PLB2
Tau
 mice (6- & 12-month of age) 
probed for PHF-1 phospho-Tau levels. B) Total PHF-1 positive Tau was increased at in both 6 
and 12-month old PLB2
Tau
 samples relative to age-matched controls. C) Significant 
elevations were detected at 55 and 50 kDa (bands analysed individually) in 6-month old 
PLB2
Tau 
mice. D) By 12-month of age, the increase in PHF-1 phospho-Tau was more 
pronounced (all detected Tau bands) cf. PLB1
WT
. E) Blots from lysates probed with CP-13. F) 
Elevated levels of total CP-13 phospho-Tau were detected in 6 and 12-month old PLB2
Tau
 
samples relative to age-matched controls. G) Individual analysis of CP-13 positive Tau bands 
demonstrated a selective increase of Ser202 phosphorylation of the 50 kDa Tau species in 
6-month old PLB2
Tau
 samples. H) Similar to PHF-1, phosphorylation levels increased with 
age, i.e. at 12 months significantly higher CP-13 signals were detected for all Tau bands (60, 
55 & 50 kDa). J) An increase  in AT-8 positive total Tau was detected at 6 and 12-months of 
age PLB2Tau samples, comprising of K) increased 50 kDa band AT-8 phosphorylation in 6-
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month old PLB2Tau samples and L) increased AT-8 phosphorylation within 50 and 60 kDa 
bands in 12-month old PLB2Tau samples.  All data were adjusted to total Tau expression 
prior to normalisation to age matched PLB
WT
 samples and are presented as  means + SEM 
relative to WT (rel. to WT). *=p<0.05 and **=p<0.01, ***=p<0.001. [Figure 3 – 2 column 
fit] 
 
Figure 4: Open field water maze: Intact acquisition and recall in PLB2
Tau
 mice.  
Spatial learning and recall abilities in PLB
WT
 and PLB2
Tau
 mice were assessed in a standard 
open field water maze paradigm. A) At 6-months of age, PLB2
Tau
 mice performed 
equivalent to age-matched PLB
WT
 mice during acquisition. B) Swim speed during acquisition 
was also unaffected. C) Both PLB
WT
 and PLB2
Tau
 mice demonstrated retention for the 
trained platform position in the subsequent probe trial. D) 12-month old PLB2
Tau
 mice were 
also not significantly affected during acquisition. E) However, a comparison of swim speeds 
demonstrated an accelerated rate for PLB2
Tau
 mice relative to PLB
WT
 mice. F) Memory 
retention of platform position did not differ between groups at 12-month of age. 
Acquisition data and swim speed are expressed for each day (means ±SEM), and probe data 
is shown as % time in target quadrant (means +SEM). $ indicates statistical significance cf. 
chance level (p<0.05). [Figure 4 – 1 column fit] 
 
Figure 5: Homecage spatial learning and reversal learning in PLB2
Tau
 mice.  
Ai) No corner bias was observed during the habituation phase (‘Habit’) of the task (all 
corners supplying water) for either genotype. At 6-month old, PLB
WT
 mice displayed 
preference for the water supplying corner (% correct visits significantly above chance level) 
and thus retention for water access location during the 12 hr experimental phase (Test). 
PLB2
Tau
 mice failed to attain significance. Aii) During a 12 hr reversal phase (Rev.), PLB
WT
 
and PLB2
Tau
 mice demonstrated a strong bias towards the water supplying corner, though 
notably PLB2
Tau
 mice exhibited a weaker preference for the new location compared to 
PLB
WT
 mice. B) Total corner visits were reduced in PLB2
Tau
 when compared to PLB
WT
 mice, 
in both i) the initial learning phase and ii) in reversal learning. C) At 12-month of age, 
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PLB2
Tau
 mice failed to exhibit a corner preference during the spatial learning task in contrast 
to the intact corner learning of age matched PLB
WT
 mice. D) PLB2
Tau
 mice again 
demonstrated reduced total corner visits at 12-month of age. Data are expressed as % 
correct corner visits (means + SEM) and total corner visits (means + SEM). $= p<0.05: 
comparison with chance level and *= p<0.05: comparison cf. PLB
WT
 controls. [Figure 5 – 1 
column fit] 
 
Figure 6: Social transmission of food preference in PLB2
Tau
 mice.  
Social interaction for cued food presentation was followed by either a short (15 mins; 
short-term memory [STM]) or long delay (24 hr; long-term memory [LTM]) prior to the 
mice being tested for recall via the presentation of correct and incorrect food. A) Analysis 
of food intake (g) demonstrated that PLB
WT
 mice consumed significantly more correct food 
(cued) during both STM and LTM tasks in comparison to incorrect food (non-cued), 
whereas PLB2
Tau
 mice did not. B) When considered relative to total food consumed (%), 
PLB2
Tau
 mice failed to demonstrate preference for cued food in either STM or LTM tasks, in 
contrast to age-matched PLB
WT
 mice. Data are presented as means + SEM. $= p<0.05 
depicts significance vs. chance, *=p<0.05, **=p<0.01 and ***=p<0.001 is given for within-
group comparisons or relative to WT’s. [Figure 6 – 1 column fit] 
 
Figure 7: Emotional behaviour of PLB2
Tau
 mice.  
At 6 months, PLB2
Tau
 mice demonstrated heightened anxiety when assessed in the elevated 
plus maze (EPM). A) Relative to PLB
WT
 mice, PLB2
Tau
 mice spent an increased amount of 
time (%) in the closed arms and less time within the open arms of the apparatus.  
The hedonistic motivation / pleasure seeking behaviour of PLB2
Tau
 mice was assessed by a 
3-day sucrose preference test (B).  Bi) PLB
WT
 mice demonstrated a clear preference for 
sucrose over untreated water on all days (%), PLB2
Tau
 mice failed to display a preference for 
sucrose on day 1, only discriminating for sucrose solution on days 2 and 3. Bii) Lick data for 
water and sucrose over the 3 days of testing confirmed that both PLB
WT
 and PLB2
Tau
 mice 
presented with an overall preference for sucrose. However, PLB2
Tau
 mice performed fewer 
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sucrose licks and increased water licks when compared with WT’s. Data are illustrated as % 
time in zones, % sucrose corner visits and % licks (mean +SEM), $= p<0.05 indicates results 
relative to chance level, *=p<0.05 **=p<0.01 and ***=p<0.001 depicts differences between 
PLB2
Tau
 and PLB
WT
 mice.  [Figure 7 – 2 column fit] 
 
Figure 8: Intact motor function of PLB2
Tau
 mice.  
The motor performance of 14-month old PLB
WT
 and PLB2
Tau
 mice was assessed in the 
balance beam paradigm and quantified as latency to traverse A) square or B) round beams 
of various diameters (5, 11 and 28 mm). No motor deficits were observed in PLB2
Tau
 mice 
compared to PLB
WT
 in either of the tests. Note the slight improvement in the latency of 
PLB2
Tau
 mice apparent for the 28 mm square beam test. Data are presented as mean time 
(in seconds) ± SEM. *=p<0.05 refers to results from a Bonferroni multiple comparisons 
post-test. [Figure 8 – 1 column fit] 
 
Figure 9: Habituation to a novel environment, exploratory activity and circadian rhythm 
in PLB2
Tau
 mice.  
A) Non-linear regression of exploratory activity (for mean distance moved [cm], 10 min 
bins) during the 3 hr habituation phase indicated lower activity in 6-month old PLB2
Tau 
when compared to PLB
WT 
mice. B) Reduced ambulatory activity of PLB2
Tau
 mice was also 
evident over the following 4 days (mean distance moved, 1hr bins) and when pooled across 
the 96 hr observation period (C). Basic circadian activity was maintained in PLB2
Tau
 mice, 
with a decreased activity observed for data pooled during light and dark phases (D). Data 
are shown as mean distance moved ± or + SEM. **=p<0.01. [Figure 9 – 2 column fit] 
 
Figure 10: Vigilance stage composition and EEG power spectra of PLB2
Tau
 mice.  
A) PLB2
Tau
 mice spent an increased time awake (wakefulness, W) cf. PLB
WT
 mice, which 
corresponded to a reduction in NREM (NR) sleep during the midday recording period (4 
hrs), without alterations in REM (R) occurrence. Recordings during the midnight period did 
not reveal significant difference in vigilance stage composition. B) Corresponding stage-
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specific EEG spectra (pooled per group and vigilance stage from the 8 hrs data set) 
demonstrated stage- and region-specific alterations. Data are expressed as means +SEM (A) 
and means ±SEM (B). Overall effects of genotype and interactions are reported on the right, 
band-specific genotype effects (*) and interactions ($) are also indicated as */$=p<0.05 
**/$$=p<0.01 and ***/$$$=p<0.001.  [Figure 10 – 2 column fit] 
 
Figure 11: Hippocampal slice physiology in PLB2
Tau
 mice.  
Basic synaptic transmission and LTP were assessed in hippocampal slices from 6, 12 and 24 
months old PLB2
Tau
 and PLB
WT
 mice.  IO curves of synaptic transmission are shown as fEPSP 
slope in relation to (A) stimulus intensity [stim. intensity] and (B) presynaptic fibre volley. 
When considered as a function of stimulus intensity, synaptic transmission was only 
affected in 24 months old PLB2
Tau
 mice relative to PLB
WT 
mice. In contrast, fEPSP slope 
plotted relative to the presynaptic fibre volley demonstrated a robust decrease in synaptic 
efficiency in all age groups of PLB2
Tau
 mice compared to PLB
WT
 mice. C) Hippocampal CA1 
LTP was overall unaffected in all age groups of PLB2
Tau
 mice, though a trend for decreased 
potentiation was observed at 12 months cf. PLB
WT
 controls. Data are expressed as mean 
fEPSP slope +SEM for IO curves and as fEPSP slope (% of pre-tetanus baseline) +SEM for 
LTP. ***=p<0.001. [Figure 11 – 2 column fit] 
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 Tau variant 
(name) 
Iso-
form 
Pro-
moter 
Expression 
(fold) 
Region  
Onset 
(m) 
Histopathology Behavioural /cognitive phenotype Reference 
P301L  
(JNPL3) 
4R2N mPrP 2 CNS + S.C. 4
b
 
P-Tau / NFTs in F.B .+ S.C. + B.S. 
Spinal motor neuron loss (>8m) 
Motor deficits Lewis et al., 2000 
P301L 4R2N Thy 1.2 N.R. CNS + S.C. 3
a
 P-Tau / NFT in F.B. + S.C. + B.S. No motor deficit Gotz et al., 2001 
V337M 4R2N PDGF-β 0.1 
CNS:  
F.B  12
b
 P-Tau / NTFs in F.B. 
No WM deficit  
Increase in EPM open arms (↓anxiety) 
Tanemura et al., 2001 
+2002 
P301S 4R0N Thy 1 2  CNS + S.C. 3
b
 
P-Tau / NFTs in F.B .+ S.C.                
Spinal neuron loss     
Muscle atrophy 
Motor deficits  
WM deficits (↓memory)  
Increased time in OF centre (↓anxiety) 
Allen et al., 2002   
Scattoni et al., 2010 
R406W 4R2N CaMKII 0.2 
CNS: 
F.B 
16
b
 P-Tau / NFTs in F.B. 
No motor deficits 
Cued/Contextual fear conditioning (↓memory) 
No difference in L/D box (−anxiety)  
PPI deficits (↑psychosis)  
Immobility in forced swim test (↑depression) 
Tatebayash et al., 2002    
Egashira et al., 2005 
R406W 4R2N mPrP 10 CNS + S.C. 2
a
 P- Tau / NFTs in F.B .+ S.C.  N.R. Zhang et al., 2004 
P301L (Tg4510) 4R0N 
CaMKII 
(Tet) 
13 
CNS:  
F.B 
2-4
b
 
P-Tau / NFTs in F.B. 
Cortico-spinal neuron loss (>10m) 
Motor deficits 
WM deficits (↓memory) 
Contextual fear conditioning (↓memory) 
PPI deficits ( ↑psychosis) 
SantaCruz et al., 2005    
Ramsden et al., 2005      
Hunsburger et al.,2014       
Koppel et al., 2014 
P301S+ G227V  
(THY-Tau22) 
4R1N Thy 1.2 5 CNS + S.C. 3
b
 P-Tau /NFTs in F.B. 
No motor deficits  
WM deficit (↓memory)  
STFP deficit (↓memory) 
Y-maze deficit (↓memory)  
contextual fear conditioning (↓memory)  
Increase in EPM open arms (↓anxiety) 
immobility in tail suspension test (↑depression) 
Reduced reward performance (↑anhedonia) 
Schindowski et al., 2006 
Van der Jeugd et al., 
2011+ 2013 
P301S  
(PS19) 
4R1N mPrP 5 CNS + S.C. 3
b
 
P-Tau / NFTs in F.B. + S.C.  
Spinal neuron loss    
Muscle atrophy 
Motor deficits  
WM deficits (↓memory) 
Increase in EPM open arms (↓anxiety) 
 PPI deficits (↑psychosis) 
Decreased hot plate threshold ( ↑nociception) 
No change in forced swim test 
Yoshiyama et al., 2007 
Takeuchi et al., 2011 
K257T +P301S   
(DM Tau-tg) 
4R0N Tau 0.1 
CNS + 
 S.C 6
b
 P-Tau and NFTs in F.B. 
No motor deficits  
WM deficits (↓memory) 
RAWM deficits (↓memory) 
Rosenmann et al., 2008 
P301L  
(rTg TauEC) 
4R0N 
CAMKII / 
neuropsin  
N.R 
E.C 
hippocampus 
3a 
P-Tau and NFTs in E.C and 
hippocampus 
Propagation of pathology via 
synaptic connections 
Contextual fear conditioning deficit (↓memory) 
De Calignon et al., 2012 
Polydoro et al., 2014 
P301L 
(P301L KI) 
 All 
Endo 
Tau 0 
CNS + 
 S.C 
N.A 
Tau hypophosphorylation 
No NFTs 
Reduced Microtubule association 
Mitochondria transport 
abnormalities 
No motor deficits 
No deficits in  STFP  
Enhanced  locomotion 
Gilley et al., 2012 
V337M + 
R406W (TMHT) 
4R2N mThy-1 2  CNS 5
b
 P-Tau /NFTs in F.B. 
No motor deficits  
WM deficits (↓memory) 
Immobility forced swim test (↑depression) 
Impairment in buried cookie test (↓olfaction) 
Flunkert et al., 2013 
P301S+ 
G335D 
(Line 66) 
4R2N mThy-1 2 CNS 6
b
 P-Tau/NFTs in F.B. 
Motor deficits 
No WM deficit  
Reduced thigmotaxis (↓anxiety) 
Melis et al., 2015 
Table 1
